Open0.803 | Close0.747 |
Vol / Avg.7.171M / 6.671M | Mkt Cap286.083M |
Day Range0.742 - 0.810 | 52 Wk Range0.613 - 3.070 |
Agenus Stock (NASDAQ: AGEN) stock price, news, charts, stock research, profile.
Open0.803 | Close0.747 |
Vol / Avg.7.171M / 6.671M | Mkt Cap286.083M |
Day Range0.742 - 0.810 | 52 Wk Range0.613 - 3.070 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.190 | -0.160 | 0.0300 | ||||
REV | 24.330M | 24.314M | -16.000K |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.200 | -0.200 | 0.0000 | ||||
REV | 24.120M | 25.296M | 1.176M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-08 | HC Wainwright & Co. | Emily Bodnar | Reiterates | BuyBuy | Maintains | - | 8.00 |
2023-07-03 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.30 |
2023-07-03 | HC Wainwright & Co. | Emily Bodnar | Reiterates | BuyBuy | Maintains | - | 8.00 |
2023-06-06 | Baird | Colleen Kusy | Initiates Coverage On | Outperform | Announces | - | 8.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AGEN | Agenus | -7.48% | 286.1M |
IMNM | Immunome | 0.39% | 330.3M |
KALV | KalVista Pharma | -9.03% | 280.7M |
HUMA | Humacyte | -0.71% | 290M |
PGEN | Precigen | 0.85% | 293.7M |
You can purchase shares of Agenus (NASDAQ: AGEN) through any online brokerage.
Other companies in Agenus’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), Humacyte (NASDAQ:HUMA), Precigen (NASDAQ:PGEN) and Voyager Therapeutics (NASDAQ:VYGR).
The latest price target for Agenus (NASDAQ: AGEN) was reported by HC Wainwright & Co. on Tuesday, August 8, 2023. The analyst firm set a price target for 8.00 expecting AGEN to rise to within 12 months (a possible 966.81% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Agenus (NASDAQ: AGEN) is $0.7499 last updated December 9, 2023 at 12:35 AM UTC.
There is no dividend information for Agenus.
Agenus’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Agenus.
Agenus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.